Fundraising FoxGaruda Therapeutics
Cambridge, US · Founded 2021 · Delaware corporation · 1 known investors
Find your way into Garuda Therapeutics
Sign up to see every warm intro you have to Garuda Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Garuda Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Garuda Therapeutics was founded in 2021 by Dhvanit I Shah.
DI
Dhvanit I ShahChief Executive Officer of the Issuer
DK
David KirskeExecutive
AC
Adam CraigExecutive
Board
Investors · 1
Reported raises · per SEC filings
Form D private placements$158M disclosed across 3 rounds · 2021–2024
▶$47.7MraisedOct 2024 · 16 investors · BiotechnologyRule 506(b)
▶$47.7MraisedOct 2024 · 16 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Geoff MeyersonDirector
- Raymond KelleherDirector
- Eric AguiarDirector
- Steve LiapisDirector
- Rahul SinghviDirector
- David KirskeExecutive Officer
- Carl GordonDirector
- Adam CraigExecutive Officer, Director
- Amount sold
- $47.7M
- First sale
- Oct 2024
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$62.1MraisedFeb 2023 · 13 investors · BiotechnologyRule 506(b)
▶$62.1MraisedFeb 2023 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Daniel JanseDirector
- Eric AguiarDirector
- Carl GordonDirector
- Dhvanit I ShahExecutive Officer, Director
- Raymond KelleherDirector
- Rahul SinghviDirector
- Laurence ReidDirector
- Offering amount
- $62.9M
- Amount sold
- $62.1M
- First sale
- Jan 2023
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$48.1MraisedSep 2021 · 23 investors · BiotechnologyRule 506(b)
▶$48.1MraisedSep 2021 · 23 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Rahul SinghviDirector
- Eric AguiarDirector
- Shaan GandhiDirector
- Dhvanit I ShahExecutive Officer, Director
- Carl GordonDirector
- Offering amount
- $71.8M
- Amount sold
- $48.1M
- Sales commissions
- $2M
- Proceeds to insiders
- $970K
- Placement agents
- Locust Walk Securities, LLC
- First sale
- Sep 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Garuda Therapeutics?
- Garuda Therapeutics was founded by Dhvanit I Shah in 2021.
- Who are Garuda Therapeutics's investors?
- Garuda Therapeutics's investors include Aisling Capital.
- How much funding has Garuda Therapeutics raised?
- Garuda Therapeutics has disclosed $158M raised across 3 rounds.
- Where is Garuda Therapeutics headquartered?
- Garuda Therapeutics is headquartered in Cambridge, US.